Supplementary Figure 4 from Matrix Metalloproteinase-14 (Mt1-Mmp)–mediated Endoglin Shedding Inhibits Tumor Angiogenesis

Lukas J.A.C. Hawinkels,Patricia Kuiper,Eliza Wiercinska,Hein W. Verspaget,Zhen Liu,Evangelia Pardali,Cornelis F.M. Sier,Peter ten Dijke

DOI: https://doi.org/10.1158/0008-5472.22383150

2023-01-01

Abstract:Supplementary Figure 4 from Matrix Metalloproteinase-14 (MT1-MMP)–Mediated Endoglin Shedding Inhibits Tumor Angiogenesis

What problem does this paper attempt to address?

Data from Matrix Metalloproteinase-14 (Mt1-Mmp)–mediated Endoglin Shedding Inhibits Tumor Angiogenesis

Lukas J. A. C. Hawinkels,Patricia Kuiper,Eliza Wiercinska,Hein W. Verspaget,Zhen Liu,Evangelia Pardali,Cornelis F. M. Sier,Peter ten Dijke

DOI: https://doi.org/10.1158/0008-5472.can-09-4466

IF: 11.2

2010-01-01

Cancer Research

Abstract:AbstractEndoglin is a transforming growth factor-β coreceptor with a crucial role in angiogenesis. A soluble form of endoglin is present in the circulation, but the role of soluble endoglin (sEndoglin) is poorly understood. In addition, the endoglin shedding mechanism is not known. Therefore, we examined the role of sEndoglin in tumor angiogenesis and the mechanism by which the extracellular domain of endoglin is released from the membrane.In colorectal cancer specimens, we observed high endothelial endoglin protein expression, accompanied with slightly lower sEndoglin levels in the circulation, compared with healthy controls. In vitro analysis using endothelial sprouting assays revealed that sEndoglin reduced spontaneous and vascular endothelial growth factor–induced endothelial sprouting. Human umbilical vascular endothelial cells were found to secrete high levels of sEndoglin. Endoglin shedding was inhibited by matrix metalloproteinase (MMP) inhibitors and MMP-14 short hairpin RNA, indicating MMP-14 as the major endoglin shedding protease. Coexpression of endoglin and membrane-bound MMP-14 led to a strong increase in sEndoglin levels. Endoglin shedding required a direct interaction between endoglin and membrane-localized MMP-14. Using cleavage site mutants, we determined that MMP-14 cleaved endoglin at a site in close proximity to the transmembrane domain. Taken together, this study shows that MMP-14 mediates endoglin shedding, which may regulate the angiogenic potential of endothelial cells in the (colorectal) tumor microenvironment. Cancer Res; 70(10); 4141–50. ©2010 AACR.
Tumor and Stem Cell Biology Cancer Research Matrix Metalloproteinase-14 ( MT 1-MMP ) – Mediated Endoglin Shedding Inhibits Tumor Angiogenesis

Lukas J. A. C. Hawinkels,Patricia Kuiper,Eliza Wiercinska,Hein W. Verspaget,Zhen Liu,Evangelia Pardali,Cornelis F. M. Sier,Peter ten Dijke

2010-01-01

Abstract:Authors' A for Biomed Leiden Uni Note: Sup Research O Correspon ical Center, 9600, 2300 526-8270; E
Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

Nikolaos A. Dallas,Shaija Samuel,Ling Xia,Fan,Michael J. Gray,Sung Hoon Lim,Lee M. Ellis

DOI: https://doi.org/10.1158/1078-0432.ccr-07-4478

IF: 13.801

2008-01-01

Clinical Cancer Research

Abstract:Endoglin (CD105) is an accessory protein of the transforming growth factor-beta receptor system expressed on vascular endothelial cells. Mutation of the endoglin gene is associated with hereditary hemorrhagic telangiectasias, or Osler-Weber-Rendu syndrome, and has been studied extensively in the context of this disease. The expression of endoglin is elevated on the endothelial cells of healing wounds, developing embryos, inflammatory tissues, and solid tumors. Endoglin is a marker of activated endothelium, and its vascular expression is limited to proliferating cells. Recent studies identified endoglin expression in several solid tumor types, with the level of expression correlating with various clinicopathologic factors including decreased survival and presence of metastases. Attempts to target endoglin and the cells that express this protein in tumor-bearing mice have yielded promising results.
Supplementary Figure S4 from Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis

Madelon Paauwe,Mark J.A. Schoonderwoerd,Roxan F.C.P. Helderman,Tom J. Harryvan,Arwin Groenewoud,Gabi W. van Pelt,Rosalie Bor,Danielle M. Hemmer,Henri H. Versteeg,B. Ewa Snaar-Jagalska,Charles P. Theuer,James C.H. Hardwick,Cornelis F.M. Sier,Peter ten Dijke,Lukas J.A.C. Hawinkels

DOI: https://doi.org/10.1158/1078-0432.22468019.v1

2023-01-01

Abstract:HEK293 invasion, BMP-9 expression by CRC cells and CAFs, invasion assays
Supplementary Figure Legends 1-2 from Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment

Tanja Holopainen,Huilian Huang,Caiping Chen,Kyung Eun Kim,Luqing Zhang,Fei Zhou,Wencan Han,Chaojun Li,Jun Yu,Jun Wu,Gou Young Koh,Kari Alitalo,Yulong He

DOI: https://doi.org/10.1158/0008-5472.22379397.v1

2023-01-01

Abstract:Supplementary Figure Legends 1-2 from Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment
Deficiency for Endoglin in Tumor Vasculature Weakens the Endothelial Barrier to Metastatic Dissemination.

Charlotte Anderberg,Sara I. Cunha,Zhenhua Zhai,Eliane Cortez,Evangelia Pardali,Jill R. Johnson,Marcela Franco,Marta Paez-Ribes,Ross Cordiner,Jonas Fuxe,Bengt R. Johansson,Marie-Jose Goumans,Oriol Casanovas,Peter ten Dijke,Helen M. Arthur,Kristian Pietras

DOI: https://doi.org/10.1084/jem.20120662

IF: 11.2

2013-01-01

Cancer Research

Abstract:Therapy-induced resistance remains a significant hurdle to achieve long-lasting responses and cures in cancer patients. We investigated the long-term consequences of genetically impaired angiogenesis by engineering multiple tumor models deprived of endoglin, a co-receptor for TGF-β in endothelial cells actively engaged in angiogenesis. Tumors from endoglin-deficient mice adapted to the weakened angiogenic response, and refractoriness to diminished endoglin signaling was accompanied by increased metastatic capability. Mechanistic studies in multiple mouse models of cancer revealed that deficiency for endoglin resulted in a tumor vasculature that displayed hallmarks of endothelial-to-mesenchymal transition, a process of previously unknown significance in cancer biology, but shown by us to be associated with a reduced capacity of the vasculature to avert tumor cell intra- and extravasation. Nevertheless, tumors deprived of endoglin exhibited a delayed onset of resistance to anti-VEGF (vascular endothelial growth factor) agents, illustrating the therapeutic utility of combinatorial targeting of multiple angiogenic pathways for the treatment of cancer.
Supplementary Figures from the Amino-Terminal Oligomerization Domain of Angiopoietin-2 Affects Vascular Remodeling, Mammary Gland Tumor Growth, and Lung Metastasis in Mice

Emmi Kapiainen,Minna K. Kihlström,Riikka Pietilä,Mika Kaakinen,Veli‐Pekka Ronkainen,Hongmin Tu,Anne Heikkinen,Raman Devarajan,Ilkka Miinalainen,Anna Laitakari,Mohammadhassan Ansarizadeh,Qin Zhang,Gong‐Hong Wei,Lloyd W. Ruddock,Taina Pihlajaniemi,Harri Elamaa,Lauri Eklund

DOI: https://doi.org/10.1158/0008-5472.22426518

2023-01-01

Abstract:Supplementary Figure S1: Amino acid sequence of ANGPT2, ANGPT2443 and ANGTPT2DAP. Supplementary Figure S2: Competitive inhibition of ANGPT4-induced TIE2 phosphorylation by ANGPT2 isoforms. Supplementary Figure S3. TIE2 phosphorylation by ANGPT2 isoforms at the retracting cell edges. Supplementary Figure S4. Generation of Angpt2443 allele and the effects of Angpt2443 expression on the retina. Supplementary Figure S5. MMTV-PyMT mammary gland tumor model. Supplementary Figure S6. ANGPT2 at the Weibel-Palade bodies and the subendothelial space. Supplementary Figure S7. B16F10 melanoma lung colonization model. Supplementary Figure S8. E0771 breast cancer cell transplantation model.
Endoglin for tumor imaging and targeted cancer therapy.

Madelon Paauwe,Peter ten Dijke,Lukas J A C Hawinkels

DOI: https://doi.org/10.1517/14728222.2013.758716

IF: 6.797

2013-01-01

Expert Opinion on Therapeutic Targets

Abstract:Introduction: Although cancer treatment has evolved substantially in the past decades, cancer-related mortality rates are still increasing. Therapies targeting tumor angiogenesis, crucial for the growth of solid tumors, mainly target vascular endothelial growth factor (VEGF) and have been clinically applied during the last decade. However, these therapies have not met high expectations, which were based on therapeutic efficacy in animal models. This can partly be explained by the upregulation of alternative angiogenic pathways. Therefore, additional therapies targeting other pro-angiogenic pathways are needed. Areas covered: The transforming growth factor (TGF)-beta signaling pathway plays an important role in (tumor) angiogenesis. Therefore, components of this pathway are interesting candidates for anti-angiogenic therapy. Endoglin, a co-receptor for various TGF-beta family members, is specifically over-expressed in tumor vessels and endoglin expression is associated with metastasis and patient survival. Therefore, endoglin might be a good candidate for anti-angiogenic therapy. In this review, we discuss the potential of using endoglin to target the tumor vasculature for imaging and therapeutic purposes. Expert opinion: Considering the promising results from various in vitro studies, in vivo animal models and the first clinical trial targeting endoglin, we are convinced that endoglin is a valuable tool for the diagnosis, visualization and ultimately treatment of solid cancers.
Supplementary Figure 2 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

Xuebo Chen,Leying Zhang,Ian Y. Zhang,Junling Liang,Huaqing Wang,Mao Ouyang,Shihua Wu,Anna Carolina Carvalho da Fonseca,Lihong Weng,Yasuhiko Yamamoto,Hiroshi Yamamoto,Rama Natarajan,Behnam Badie

DOI: https://doi.org/10.1158/0008-5472.22402857.v1

2023-01-01

Abstract:Supplementary Fig. 2: RAGE ablation in GL261 gliomas results in the formation of dilated, leaky vessels.
Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis

Claudia Ollauri-Ibáñez,Elena Núñez-Gómez,Cristina Egido-Turrión,Laura Silva-Sousa,Elena Díaz-Rodríguez,Alicia Rodríguez-Barbero,José M. López-Novoa,Miguel Pericacho

DOI: https://doi.org/10.1007/s10456-019-09703-y

IF: 10.658

2020-01-03

Angiogenesis

Abstract:Abstract Endoglin (CD105) is an auxiliary receptor for members of the TFG-β superfamily. Whereas it has been demonstrated that the deficiency of endoglin leads to minor and defective angiogenesis, little is known about the effect of its increased expression, characteristic of several types of cancer. Angiogenesis is essential for tumor growth, so high levels of proangiogenic molecules, such as endoglin, are supposed to be related to greater tumor growth leading to a poor cancer prognosis. However, we demonstrate here that endoglin overexpression do not stimulate sprouting or vascularization in several in vitro and in vivo models. Instead, steady endoglin overexpression keep endothelial cells in an active phenotype that results in an impairment of the correct stabilization of the endothelium and the recruitment of mural cells. In a context of continuous enhanced angiogenesis, such as in tumors, endoglin overexpression gives rise to altered vessels with an incomplete mural coverage that permit the extravasation of blood. Moreover, these alterations allow the intravasation of tumor cells, the subsequent development of metastases and, thus, a worse cancer prognosis.

peripheral vascular disease
Supplementary Table S4 from Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis

Madelon Paauwe,Mark J.A. Schoonderwoerd,Roxan F.C.P. Helderman,Tom J. Harryvan,Arwin Groenewoud,Gabi W. van Pelt,Rosalie Bor,Danielle M. Hemmer,Henri H. Versteeg,B. Ewa Snaar-Jagalska,Charles P. Theuer,James C.H. Hardwick,Cornelis F.M. Sier,Peter ten Dijke,Lukas J.A.C. Hawinkels

DOI: https://doi.org/10.1158/1078-0432.22468001.v1

2023-01-01

Abstract:Characterization of patient-derived NFs and CAFs
Editor's Note: Tumor Escape from Endogenous, Extracellular Matrix–Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors

Namali T. Fernando,Moritz Koch,Courtney Rothrock,Lila K. Gollogly,Patricia A. D'Amore,Sandra Ryeom,Sam S. Yoon

DOI: https://doi.org/10.1158/1078-0432.ccr-24-2135

IF: 13.801

2024-10-17

Clinical Cancer Research

Abstract:The editors are publishing this note to alert readers to a concern about this article (1): in Fig. 3A, the same IHC images were used to represent the overexpression of Tsp1-6 and Endo-6.

oncology
Endoglin in Angiogenesis and Vascular Diseases

Peter ten Dijke,Marie-José Goumans,Evangelia Pardali

DOI: https://doi.org/10.1007/s10456-008-9101-9

IF: 10.658

2008-01-01

Angiogenesis

Abstract:Endoglin is a transmembrane auxillary receptor for transforming growth factor-beta (TGF-beta) that is predominantly expressed on proliferating endothelial cells. Endoglin deficient mice die during midgestation due to cardiovascular defects. Mutations in endoglin and activin receptor-like kinase 1 (ALK1), an endothelial specific TGF-beta type I receptor, have been linked to hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant vascular dysplasia characterized by telangiectases and arteriovenous malformations. Endoglin heterozygote mice develop HHT-like vascular abnormalities, have impaired tumor and post-ischemic angiogenesis and demonstrate an endothelial nitric oxide synthase-dependent deterioration in the regulation of vascular tone. In pre-eclampsia, placenta-derived endoglin has been shown to be strongly upregulated and high levels of soluble endoglin are released into the circulation. Soluble endoglin was found to cooperate with a soluble form of vascular endothelial growth factor receptor 1 in the pathogenesis of pre-eclampsia by inducing endothelial cell dysfunction. Endoglin is highly expressed in tumor-associated endothelium, and endoglin antibodies have been successfully used to target activated endothelial cells and elicit anti-angiogenic effects in tumor mouse models. These exciting advances provide opportunities for the development of new therapies for diseases with vascular abnormalities.
Endoglin is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis

Zhen Liu,Franck Lebrin,Janita A. Maring,Sander van den Driesche,Stieneke van der Brink,Maarten van Dinther,Midory Thorikay,Sabrina Martin,Kazuki Kobayashi,Lukas J. A. C. Hawinkels,Laurens A. van Meeteren,Evangelia Pardali,Jeroen Korving,Michelle Letarte,Helen M. Arthur,Charles Theuer,Marie-Jose Goumans,Christine Mummery,Peter ten Dijke

DOI: https://doi.org/10.1371/journal.pone.0086273

IF: 3.7

2014-01-01

PLoS ONE

Abstract:ENDOGLIN (ENG) is a co-receptor for transforming growth factor-β (TGF-β) family members that is highly expressed in endothelial cells and has a critical function in the development of the vascular system. Mutations in Eng are associated with the vascular disease known as hereditary hemorrhagic telangiectasia type l. Using mouse embryonic stem cells we observed that angiogenic factors, including vascular endothelial growth factor (VEGF), induce vasculogenesis in embryoid bodies even when Eng deficient cells or cells depleted of Eng using shRNA are used. However, ENG is required for the stem cell-derived endothelial cells to organize effectively into tubular structures. Consistent with this finding, fetal metatarsals isolated from E17.5 Eng heterozygous mouse embryos showed reduced VEGF-induced vascular network formation. Moreover, shRNA-mediated depletion and pharmacological inhibition of ENG in human umbilical vein cells mitigated VEGF-induced angiogenesis. In summary, we demonstrate that ENG is required for efficient VEGF-induced angiogenesis.
Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma

E Pardali,D W J van der Schaft,E Wiercinska,A Gorter,P C W Hogendoorn,A W Griffioen,P ten Dijke

DOI: https://doi.org/10.1038/onc.2010.418

IF: 8.756

2010-01-01

Oncogene

Abstract:Tumor cell plasticity enables certain types of highly malignant tumor cells to dedifferentiate and engage a plastic multipotent embryonic-like phenotype, which enables them to ‘adapt’ during tumor progression and escape conventional therapeutic strategies. This plastic phenotype of aggressive cancer cells enables them to express endothelial cell-specific markers and form tube-like structures, a phenotype that has been linked to aggressive behavior and poor prognosis. We demonstrate here that the transforming growth factor (TGF)-β co-receptor endoglin, an endothelial cell marker, is expressed by tumor cells and its expression correlates with tumor cell plasticity in two types of human cancer, Ewing sarcoma and melanoma. Moreover, endoglin expression was significantly associated with worse survival of Ewing sarcoma patients. Endoglin knockdown in tumor cells interferes with tumor cell plasticity and reduces invasiveness and anchorage-independent growth in vitro . Ewing sarcoma and melanoma cells with reduced endoglin levels showed reduced tumor growth in vivo . Mechanistically, we provide evidence that endoglin, while interfering with TGF-β signaling, is required for efficient bone morphogenetic protein, integrin, focal adhesion kinase and phosphoinositide-3-kinase signaling in order to maintain tumor cell plasticity. The present study delineates an important role of endoglin in tumor cell plasticity and progression of aggressive tumors.
Supplementary Figure S2 from Endostatin Has ATPase Activity, Which Mediates Its Antiangiogenic and Antitumor Activities

Shan Wang,Xin-an Lu,Peng Liu,Yan Fu,Lin Jia,Shunli Zhan,Yongzhang Luo

DOI: https://doi.org/10.1158/1535-7163.22502701.v1

2023-01-01

Abstract:Supplementary Figure S2. Bioluminescent assays
Supplementary Movie 1 from the Amino-Terminal Oligomerization Domain of Angiopoietin-2 Affects Vascular Remodeling, Mammary Gland Tumor Growth, and Lung Metastasis in Mice

Emmi Kapiainen,Minna K. Kihlström,Riikka Pietilä,Mika Kaakinen,Veli-Pekka Ronkainen,Hongmin Tu,Anne Heikkinen,Raman Devarajan,Ilkka Miinalainen,Anna Laitakari,Mohammadhassan Ansarizadeh,Qin Zhang,Gong-Hong Wei,Lloyd Ruddock,Taina Pihlajaniemi,Harri Elamaa,Lauri Eklund

DOI: https://doi.org/10.1158/0008-5472.22426512

2023-01-01

Abstract:Visualization of basal cell surface of GFP-HUVECs
Supplementary Figure 1 from Binding of the JmjC Demethylase JARID1B to LSD1/NuRD Suppresses Angiogenesis and Metastasis in Breast Cancer Cells by Repressing Chemokine CCL14

Qian Li,Lei Shi,Bin Gui,Wenhua Yu,Jiamu Wang,Di Zhang,Xiao Han,Zhi Yao,Yongfeng Shang

DOI: https://doi.org/10.1158/0008-5472.22388579

2023-01-01

Abstract:<p>PDF file - 57K</p>
Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor

Marcin Stawowczyk,Max D Wellenstein,Sharrell B Lee,Shira Yomtoubian,Anna Durrans,Hyejin Choi,Navneet Narula,Nasser K Altorki,Dingcheng Gao,Vivek Mittal

DOI: https://doi.org/10.1016/j.neo.2016.11.005

IF: 6.218

Neoplasia

Abstract:Molecularly targeted therapies benefit approximately 15-20% of non-small cell lung cancer (NSCLC) patients carrying specific drug-sensitive mutations. Thus, there is a clinically unmet need for the identification of novel targets for drug development. Here, we performed RNA-deep sequencing to identify altered gene expression between malignant and non-malignant lung tissue. Matrix Metalloproteinase 14 (MMP14), a membrane-bound proteinase, was significantly up-regulated in the tumor epithelial cells and intratumoral myeloid compartments in both mouse and human NSCLC. Overexpression of a soluble dominant negative MMP14 (DN-MMP14) or pharmacological inhibition of MMP14 blocked invasion of lung cancer cells through a collagen I matrix in vitro and reduced tumor incidence in an orthotopic K-RasG12D/+p53-/- mouse model of lung cancer. Additionally, MMP14 activity mediated proteolytic processing and activation of Heparin-Binding EGF-like Growth Factor (HB-EGF), stimulating the EGFR signaling pathway to increase proliferation and tumor growth. This study highlights the potential for development of therapeutic strategies that target MMP14 in NSCLC with particular focus on MMP14-HB-EGF axis.

Supplementary Figure 4 from Matrix Metalloproteinase-14 (Mt1-Mmp)–mediated Endoglin Shedding Inhibits Tumor Angiogenesis

Data from Matrix Metalloproteinase-14 (Mt1-Mmp)–mediated Endoglin Shedding Inhibits Tumor Angiogenesis

Tumor and Stem Cell Biology Cancer Research Matrix Metalloproteinase-14 ( MT 1-MMP ) – Mediated Endoglin Shedding Inhibits Tumor Angiogenesis

Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

Supplementary Figure S4 from Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis

Supplementary Figure Legends 1-2 from Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment

Deficiency for Endoglin in Tumor Vasculature Weakens the Endothelial Barrier to Metastatic Dissemination.

Supplementary Figures from the Amino-Terminal Oligomerization Domain of Angiopoietin-2 Affects Vascular Remodeling, Mammary Gland Tumor Growth, and Lung Metastasis in Mice

Endoglin for tumor imaging and targeted cancer therapy.

Supplementary Figure 2 from RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma

Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis

Supplementary Table S4 from Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis

Editor's Note: Tumor Escape from Endogenous, Extracellular Matrix–Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors

Endoglin in Angiogenesis and Vascular Diseases

Endoglin is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis

Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma

Supplementary Figure S2 from Endostatin Has ATPase Activity, Which Mediates Its Antiangiogenic and Antitumor Activities

Supplementary Movie 1 from the Amino-Terminal Oligomerization Domain of Angiopoietin-2 Affects Vascular Remodeling, Mammary Gland Tumor Growth, and Lung Metastasis in Mice

Supplementary Figure 1 from Binding of the JmjC Demethylase JARID1B to LSD1/NuRD Suppresses Angiogenesis and Metastasis in Breast Cancer Cells by Repressing Chemokine CCL14

Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor